par Hermans, Michel P;De Coster, Olivier;Seidel, L;Albert, Adelin;Van De Borne, Philippe
Référence Blood pressure. Supplement, 1, page (5-14)
Publication Publié, 2009-10
Référence Blood pressure. Supplement, 1, page (5-14)
Publication Publié, 2009-10
Article révisé par les pairs
Résumé : | Nebivolol is a highly selective beta-adrenoreceptor antagonist with vasodilating properties. This study investigated its effect on quality of life (QoL) and blood pressure (BP) in real life conditions. In total, 1468 patients were enrolled, 12% diabetics. Nebivolol was prescribed as monotherapy, add-on or switch medication. |